The latest HIRANI news updates.
The “AIMS for Health Innovation – All-Island MedTech SMEs for Health Innovation”, funded by InterTradeIreland’s SYNERGY programme, is a joint initiative between Health Innovation Research Alliance Northern Ireland (HIRANI) and Health Innovation Hub Ireland (HIHI).
Supported by InterTradeIreland’s Synergy initiative, the All-Island MedTech SMEs (AIMS) is being delivered by Health Innovation Hub Ireland (HIHI) and the Health Innovation Research Alliance Northern Ireland (HIRANI).
HIRANI attended the launch event in Westminster for two new strategic reports from CPI, ABHI and Cambridge Design Partnership arising from feedback from GB and NI HealthTech SMEs who were successful in obtaining funding with the Innovate UK Health Technology Regulatory and Innovation Programme (HealthTrip) Programme.
A number of Northern Ireland institutions and organisations joined forces in 2021 to take a multisectoral approach to address social isolation and loneliness as part of Connected Places Catapult’s Homes for Healthy Ageing programme.
The NHS Clinical Entrepreneur Programme (CEP) have been approached by several applicants asking for a deadline extension due to clinical and other commitments. They understand how busy you are working in the NHS, therefore have decided to extend the application deadline to 11pm on Sunday 6th November 2022.
The NHS Clinical Entrepreneur Programme is now open (until 30th October) and allows HSC staff, students studying healthcare degrees and post graduate students in any discipline related to health innovation (including health data, bio-engineering etc) to develop on an innovative idea which will benefit the wider patient and staff community throughout the HSC.
HIRANI and ABHI have also established the NI HealthTech Leaders’ Forum, an alliance of health technology leaders who will raise the profile of HealthTech and address obstacles that limit positive benefits to health and social care transformation and economic growth.
Sonrai Analytics, an emerging Belfast-based innovator in Artificial Intelligence (AI) data discovery, and California-based IV BioHoldings (IVBH), an innovative precision health company focusing in the area of liquid biopsy, today announced a strategic partnership to accelerate early detection of diseases with poor clinical outcomes.
This panel debate discusses opportunities for innovation and collaboration in the Life and Health Sciences sector including pathways of care, healthcare infrastructure, the challenges of an ageing population, trade, investment, funding and much more!